NCT04539379View on ClinicalTrials.gov

Evaluation of Intravenous Infusion of Labetalol Versus Magnesium Sulfate

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

March 1, 2022

Conditions
Magnesium SulfateLabetalol
Interventions
DRUG

Magnesium sulfate

intravenous infusion

DRUG

Labetolol

intravenous infusion

Trial Locations (1)

44519

Faculty of Medicine,Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04539379 - Evaluation of Intravenous Infusion of Labetalol Versus Magnesium Sulfate | Biotech Hunter | Biotech Hunter